Cumulative Illness Rating Scale Predicts Survival In Patients With Advanced Non-Small Cell Lung Cancer

被引：0
|
作者：
Dinneen, H. S. [1 ]
Dave, V. [1 ]
Gandhi, A. [1 ]
Lencina, L. [1 ]
Roy, R. [1 ]
Chang, V. T. [2 ]
机构：
[1] Rutgers New Jersey Med Sch, Newark, NJ USA
[2] Veterans Affairs New Jersey Hlth Care Syst, E Orange, NJ USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3739
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The Value of Hope: Patients' and Physicians' Preferences for Survival in Advanced Non-Small Cell Lung Cancer
    Hauber, Brett
    Penrod, John R.
    Gebben, David
    Musallam, Lina
    PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 2093 - 2104
  • [42] Maintenance Therapy Improves Survival Outcomes in Patients with Advanced Non-small Cell Lung Cancer
    Ying Wang
    Jin Yang
    You-Jin Lu
    Lung, 2015, 193 : 1057 - 1057
  • [43] Impact of Gender on Survival Outcome in Saudi Patients with Advanced Non-Small Cell Lung Cancer
    Eltaani, Hani
    Elsamany, Shereef
    Al-Fayea, Turki
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S659 - S660
  • [44] A gene expression signature predicts survival of patients with stage I non-small cell lung cancer
    Lu, Yan
    Lemon, William
    Liu, Peng-Yuan
    Yi, Yijun
    Morrison, Carl
    Yang, Ping
    Sun, Zhifu
    Szoke, Janos
    Gerald, William L.
    Watson, Mark
    Govindan, Ramaswamy
    You, Ming
    PLOS MEDICINE, 2006, 3 (12): : 2229 - 2243
  • [45] VeriStrat predicts survival in patients with non-small cell lung cancer (NSCLC) treated with erlotinib and bevacizumab
    Salmon, J. S.
    Dang, T. P.
    Billheimer, D.
    Roder, H.
    Grigorieva, J.
    Tsypin, M.
    Herbst, R. S.
    Tsao, A. S.
    Tran, H.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] Survival benefits associated with surgery for advanced non-small cell lung cancer
    David, Elizabeth A.
    Andersen, Stina W.
    Beckett, Laurel A.
    Melnikow, Joy
    Clark, James M.
    Brown, Lisa M.
    Cooke, David T.
    Kelly, Karen
    Canter, Robert J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (04): : 1620 - 1628
  • [47] A Low Advanced Lung Cancer Inflammation Index Predicts a Poor Prognosis in Patients With Metastatic Non-Small Cell Lung Cancer
    Lu, Ping
    Ma, Yifei
    Kai, Jindan
    Wang, Jun
    Yin, Zhucheng
    Xu, Hongli
    Li, Xinying
    Liang, Xin
    Wei, Shaozhong
    Liang, Xinjun
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 8
  • [48] EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib
    Buder, Anna
    Hochmair, Maximilian J.
    Setinek, Ulrike
    Pirker, Robert
    Filipits, Martin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (02) : 239 - +
  • [49] Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab
    Nardone, Valerio
    Tini, Paolo
    Pastina, Pierpaolo
    Botta, Cirino
    Reginelli, Alfonso
    Carbone, Salvatore Francesco
    Giannicola, Rocco
    Calabrese, Grazia
    Tebala, Carmela
    Guida, Cesare
    Giudice, Aldo
    Barbieri, Vito
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    Cappabianca, Salvatore
    Capasso, Rosanna
    Luce, Amalia
    Caraglia, Michele
    Mazzei, Maria Antonietta
    Pirtoli, Luigi
    Correale, Pierpaolo
    ONCOLOGY LETTERS, 2020, 19 (02) : 1559 - 1566
  • [50] Neoadjuvant Treatment Response Predicts Survival in Non-Small Cell Lung Cancer Resections
    Faulk, Adina
    Berrebt, Alexander A.
    Burke, Allen P.
    MODERN PATHOLOGY, 2016, 29 : 479A - 479A
12345